The Ministry of Health approved the use of the antiviral drug Paklovid by Pfizer.
This was announced on December 27 by the Ministry of Health.
To be specified, that the Department of Health and Pfizer signed a procurement agreement for the drug. Paksevid was approved last week by the Food and Drug Administration (FDA).
It inhibits the activity of the protease enzyme, which is essential for the replication of the virus in the body.
'' Paklovid is a pill antiviral drug intended for use by patients with mild to moderate coronavirus symptoms who are at high risk of complications. The drug is intended for home treatment. It is necessary to start taking it within 3-5 days after the onset of symptoms. Duration of treatment 5 days & quot ;, & ndash; According to the statement.
The side effects observed in the study were moderate and similar between the treatment group and the placebo group. All this confirms the efficiency and high level of safety.